Published in J Immunol on February 15, 1995
The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol (2001) 3.31
Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol (1996) 2.17
The family feud: turning off Sp1 by Sp1-like KLF proteins. Biochem J (2005) 1.83
Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol (2001) 1.67
FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells. Blood (2014) 1.57
Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell (2001) 1.52
Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J (2000) 1.49
Divide and conquer: the importance of cell division in regulating B-cell responses. Immunology (2004) 1.31
Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J Immunol (2007) 1.12
TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun (2015) 0.99
Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A(2a) adenosine receptors. J Gastroenterol (2009) 0.97
Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors. Blood (2002) 0.92
Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors. J Immunol (2009) 0.90
Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc Natl Acad Sci U S A (1996) 0.90
Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes. Infect Immun (2009) 0.86
Therapeutic potential of regulatory cytokines that target B cells. Int Immunol (2015) 0.86
Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases. Ann Rheum Dis (2001) 0.80
Emergence of anthrax edema toxin as a master manipulator of macrophage and B cell functions. Toxins (Basel) (2010) 0.79
Elevation of cAMP Levels Inhibits Doxorubicin-Induced Apoptosis in Pre- B ALL NALM- 6 Cells Through Induction of BAD Phosphorylation and Inhibition of P53 Accumulation. Int J Mol Cell Med (2015) 0.77
TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy. J Cell Mol Med (2014) 0.75
Evaluation of amniotic mesenchymal cell derivatives on cytokine production in equine alveolar macrophages: an in vitro approach to lung inflammation. Stem Cell Res Ther (2016) 0.75
Effects of granulocyte-macrophage colony-stimulating factor and cyclic AMP interaction on human neutrophil apoptosis. Mediators Inflamm (1998) 0.75
Cyclic AMP-Induced p53 Destabilization is Independent of CREB in Pre-B Acute Lymphoblastic Leukemia Cells. Int J Mol Cell Med (2017) 0.75
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74
Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol (2001) 3.55
Associations between gene expressions in breast cancer and patient survival. Hum Genet (2002) 2.67
Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res (1994) 1.93
Coordinating DNA replication initiation with cell growth: differential roles for DnaA and SeqA proteins. Proc Natl Acad Sci U S A (1996) 1.88
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy (1999) 1.83
The initiation mass for DNA replication in Escherichia coli K-12 is dependent on growth rate. EMBO J (1994) 1.80
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K. Nucleic Acids Res (1994) 1.43
Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells. Leukemia (1992) 1.39
The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. Proc Natl Acad Sci U S A (1985) 1.34
HeLa cell plasma membranes. I. 5'-Nucleotidase and ouabain-sensitive ATPase as markers for plasma membranes. J Cell Biol (1974) 1.32
Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer (1999) 1.28
Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells. Cancer Res (2000) 1.27
Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes. J Exp Med (1989) 1.26
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol (1998) 1.23
Management of anuric intensive-care patients with arteriovenous hemofiltration. Int J Artif Organs (1980) 1.21
The Escherichia coli SeqA protein destabilizes mutant DnaA204 protein. Mol Microbiol (2000) 1.21
Measurement of nuclear DNA content in fission yeast by flow cytometry. Yeast (1997) 1.16
Binucleation and polyploidization patterns in developmental and regenerative rat liver growth. Cell Prolif (1993) 1.14
Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J Exp Med (1993) 1.12
Radioimmunotherapy with alpha-particle emitters: microdosimetry of cells with a heterogeneous antigen expression and with various diameters of cells and nuclei. Radiat Res (2001) 1.12
Characterization of human mononuclear cells after positive selection with immunomagnetic particles. Scand J Immunol (1986) 1.11
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer (2011) 1.09
Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res (1996) 1.08
Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur J Immunol (1990) 1.08
Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem (1992) 1.05
Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. Hum Pathol (1989) 1.04
Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol (1991) 1.04
Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol (1999) 1.03
Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res (1987) 1.02
Multiple binding modes for Hoechst 33258 to DNA. J Histochem Cytochem (1985) 1.02
Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am J Neuroradiol (2008) 1.02
Molecular cytogenetics of human breast cancer. Cold Spring Harb Symp Quant Biol (1994) 1.02
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer (1998) 1.01
A new method for detachment of Dynabeads from positively selected B lymphocytes. J Immunol Methods (1992) 1.01
Regulation of the start of DNA replication in Schizosaccharomyces pombe. J Cell Sci (1999) 1.01
Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light. Br J Cancer (1999) 1.01
A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood (2000) 1.00
Liver takes up retinol-binding protein from plasma. J Biol Chem (1987) 1.00
A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett (1997) 0.99
Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation. Eur J Immunol (1996) 0.96
Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle. Int J Cancer (1998) 0.96
Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype. Mol Pathol (1998) 0.96
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow. Blood (2000) 0.96
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer (2013) 0.95
P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo. Br J Cancer (1995) 0.95
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer Suppl (1991) 0.94
The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress. Exp Cell Res (1996) 0.94
Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer (1996) 0.94
T-zone lymphoma with predominance of 'plasmacytoid T-cells' associated with myelomonocytic leukaemia--a distinct clinicopathological entity. J Pathol (1986) 0.94
The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein. Br J Cancer (1998) 0.93
Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis. Proc Natl Acad Sci U S A (1994) 0.92
Single cell studies on the immunological marker profile of plasmacytoid T-zone cells. Lab Invest (1987) 0.92
The B cell antigen CD75 is a cell surface sialytransferase. J Exp Med (1990) 0.92
Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage. Eur J Immunol (1987) 0.91
Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma. Int J Cancer (1989) 0.91
Thyroid antibodies in blood donors: prevalence and clinical significance. Acta Endocrinol (Copenh) (1984) 0.90
Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. Histopathology (2007) 0.90
Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RI alpha-RI beta heterodimeric complexes. J Biol Chem (1993) 0.90
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells. Stem Cells (2000) 0.90
Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer. Int J Colorectal Dis (2001) 0.90
Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids. Leukemia (1998) 0.89
Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas. Leukemia (2005) 0.89
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma. Int J Cancer (2000) 0.89
Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother (1997) 0.89
Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Cancer Res (1994) 0.88
Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: regulation of cyclin E, cyclin A, and p21(Cip1). Blood (1999) 0.87
All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors. J Immunol (1995) 0.86
Flow cytometry of bacterial cells: comparison between different flow cytometers and different DNA stains. Cytometry (1998) 0.86
Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol (1987) 0.86
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. Br J Cancer (2000) 0.85
Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. J Clin Invest (1994) 0.85
Establishment in monolayer culture and characterization of four human melanoma cell lines. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.85
All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells. Blood (1994) 0.84
Cross-linking of CD53 promotes activation of resting human B lymphocytes. J Immunol (1994) 0.84
Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells. Br J Cancer (1998) 0.84
cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation. Eur J Immunol (2000) 0.84